Status:
UNKNOWN
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
Lead Sponsor:
Benha University
Conditions:
Central Serous Chorioretinopathy
Irvine-Gass Syndrome
Eligibility:
All Genders
20-70 years
Phase:
PHASE2
PHASE3
Brief Summary
Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.
Detailed Description
Suprachoroidal triamcinolone acetonide injection is used to treat various retinal diseases, higher concentration of the injected material is found when the suprachoroidal space is used as an intraocul...
Eligibility Criteria
Inclusion
- patients diagnosed as central serous chorioretinopathy and patients with cystoid macular edema due to irvine-gass syndrome after cataract surgery.
Exclusion
- other retinal diseases that may affect CMT and final visual outcome.
- Patients with dense corneal opacity.
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05337332
Start Date
April 14 2022
End Date
June 1 2023
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Abdelshafy
Banhā, QA, Egypt, 13511